Financhill
Sell
36

DOCU Quote, Financials, Valuation and Earnings

Last price:
$44.48
Seasonality move :
-2.06%
Day range:
$43.73 - $45.94
52-week range:
$41.53 - $94.67
Dividend yield:
0%
P/E ratio:
31.13x
P/S ratio:
2.98x
P/B ratio:
4.50x
Volume:
3.8M
Avg. volume:
4.6M
1-year change:
-48.4%
Market cap:
$8.9B
Revenue:
$3B
EPS (TTM):
$1.43

Analysts' Opinion

  • Consensus Rating
    DocuSign, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 15 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $81.61, DocuSign, Inc. has an estimated upside of 83.47% from its current price of $44.48.
  • Price Target Downside
    According to analysts, the lowest downside price target is $51.96 representing -16.82% downside risk from its current price of $44.48.

Fair Value

  • According to the consensus of 20 analysts, DocuSign, Inc. has 83.47% upside to fair value with a price target of $81.61 per share.

DOCU vs. S&P 500

  • Over the past 5 trading days, DocuSign, Inc. has overperformed the S&P 500 by 0.61% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • DocuSign, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • DocuSign, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter DocuSign, Inc. reported revenues of $818.4M.

Earnings Growth

  • DocuSign, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter DocuSign, Inc. reported earnings per share of $0.40.
Enterprise value:
8.2B
EV / Invested capital:
--
Price / LTM sales:
2.98x
EV / EBIT:
30.29x
EV / Revenue:
2.60x
PEG ratio (5yr expected):
0.02x
EV / Free cash flow:
8.32x
Price / Operating cash flow:
9.53x
Enterprise value / EBITDA:
21.09x
Gross Profit (TTM):
$2.5B
Return On Assets:
7.69%
Net Income Margin (TTM):
9.57%
Return On Equity:
15.15%
Return On Invested Capital:
14.2%
Operating Margin:
10.43%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Income Statement
Revenue $2.7B $2.9B $3.2B $754.8M $818.4M
Gross Profit $2.1B $2.3B $2.5B $594.9M $644.4M
Operating Income $59.1M $179.2M $271.3M $59M $85.4M
EBITDA $152.8M $281.9M $389.7M $86.6M $115.8M
Diluted EPS $0.25 $4.85 $1.43 $0.30 $0.40
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Balance Sheet
Current Assets $1.2B $1.5B $2B $1.3B $1.3B
Total Assets $2.4B $2.7B $3.3B $3.8B $4B
Current Liabilities $1.3B $1.4B $2.2B $1.6B $1.8B
Total Liabilities $2.2B $2.3B $2.4B $1.8B $2B
Total Equity $239.6M $468.5M $965M $2B $2B
Total Debt $866.6M $803M $813.7M $111.1M $134.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Cash Flow Statement
Cash Flow Operations $845.9M $980.1M $1.1B $234.3M $290.3M
Cash From Investing -$66.1M -$213.3M -$125.4M -$43.7M -$37.7M
Cash From Financing -$226.6M -$1.3B -$998.8M -$198.3M -$270.5M
Free Cash Flow $751.5M $889.3M $987.9M $210.7M $262.9M
DOCU
Sector
Market Cap
$8.9B
$48.3M
Price % of 52-Week High
46.98%
53.33%
Dividend Yield
0%
0%
Shareholder Yield
4.82%
0.01%
1-Year Price Total Return
-48.4%
-19.29%
Beta (5-Year)
1.004
0.676
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $44.89
200-day SMA
Sell
Level $71.83
Bollinger Bands (100)
Sell
Level 55.61 - 73.19
Chaikin Money Flow
Buy
Level 180.4M
20-day SMA
Sell
Level $48.87
Relative Strength Index (RSI14)
Sell
Level 28.35
ADX Line
Sell
Level 49.81
Williams %R
Neutral
Level -74.8936
50-day SMA
Sell
Level $59.37
MACD (12, 26)
Sell
Level -4.46
25-day Aroon Oscillator
Sell
Level -76
On Balance Volume
Neutral
Level 32.5M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.2168)
Buy
CA Score (Annual)
Level (-0.0647)
Sell
Beneish M-Score (Annual)
Level (-2.1299)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.1984)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

Stock Forecast FAQ

In the current month, DOCU has received 5 Buy ratings 15 Hold ratings, and 0 Sell ratings. The DOCU average analyst price target in the past 3 months is $81.61.

  • Where Will DocuSign, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that DocuSign, Inc. share price will rise to $81.61 per share over the next 12 months.

  • What Do Analysts Say About DocuSign, Inc.?

    Analysts are divided on their view about DocuSign, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DocuSign, Inc. is a Sell and believe this share price will drop from its current level to $51.96.

  • What Is DocuSign, Inc.'s Price Target?

    The price target for DocuSign, Inc. over the next 1-year time period is forecast to be $81.61 according to 20 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 15 analysts rate the stock a Hold.

  • Is DOCU A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for DocuSign, Inc. is a Hold. 15 of 20 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of DOCU?

    You can purchase shares of DocuSign, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DocuSign, Inc. shares.

  • What Is The DocuSign, Inc. Share Price Today?

    DocuSign, Inc. was last trading at $44.48 per share. This represents the most recent stock quote for DocuSign, Inc.. Yesterday, DocuSign, Inc. closed at $44.48 per share.

  • How To Buy DocuSign, Inc. Stock Online?

    In order to purchase DocuSign, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock